Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Effect of MDR1 gene polymorphism on progression of end-stage renal disease.

Effect of MDR1 gene polymorphism on progression of end-stage renal disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Effect of MDR1 gene polymorphism on progression of end-stage renal disease. Abstract Text:

    wei-xia zhangWei-xia Zhang,bing chenBing Chen,wen zhangWen Zhang,nan chenNan Chen,zi-cheng yuZi-cheng Yu,wei-min caiWei-min Cai,

    AIM: P-glycoprotein is localized at the apical brush-border membrane of the proximal renal tubule and functions as extruding toxins and xenobiotics out of cells. The difference of P-glycoproteinos function resulted from single nucleotide polymorphisms in MDR1 (multidrug resistance gene encoding for P-gp) and may be the cause of interindividual differences in susceptibility to end-stage renal disease (ESRD). The purpose of this study is to compare the genotype frequency of C3435T and G1199A polymorphisms in MDR1 between ESRD patients and healthy controls in the Chinese population to determine whether the alteration of the P-gp function is associated with ESRD. METHODS: Two hundred and eighty-four healthy Chinese controls and 244 Chinese patients with ESRD were involved in this study. Allele specific PCR and polymerase chain reaction-restriction fragment length polymorphism assay were used to determine the genotype MDR1 G1199A and C3435T, respectively. RESULTS: The genotype distribution of 3435CC, 3435CT, and 3435TT were 0.35, 0.50, and 0.15, respectively, in the control group and 0.38, 0.47, and 0.15 in the group with the ESRD patients. No variant allele 1199G>A was found in any of the patients. The value of serum creatinine for genotypes 3435CC, 3435CT, and 3435TT in the ESRD patients were 753.8+/-276.0 mumol/L, 849.6+/-342.2 micromol/L, and 987.0+/-512.0 micromol/L, respectively. The difference between 3435TT and 3435CC reached statistical significance (P<0.05). CONCLUSION: The low expression of P-glycoprotein was not the etiological factor for the kidney disease, but it may contribute to the progression of ESRD and affect the severity. Chinese people do not carry the 1199G>A variant allele. More studies are needed to clarify the cause and interindividual differences in the susceptibility for the risk of ESRD.

    Effect of MDR1 gene polymorphism on progression of end-stage renal disease. Publishing Authors By Initials

    wx zhangWX Zhang,b chenB Chen,w zhangW Zhang,n chenN Chen,zc yuZC Yu,wm caiWM Cai,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Effect of MDR1 gene polymorphism on progression of end-stage renal disease. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Acta pharmacologica Sinica

    VOLUME: 28

    Page Numbers: 579-83

    Journal Abbreviation: Acta Pharmacol. Sin.

    ISSN: 1671-4083

    DAY: 22

    MONTH: Apr

    YEAR: 2007

    Effect of MDR1 gene polymorphism on progression of end-stage renal disease. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100956087

    Effect of MDR1 gene polymorphism on progression of end-stage renal disease. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Effect of MDR1 gene polymorphism on progression of end-stage renal disease. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Effect of MDR1 gene polymorphism on progression of end-stage renal disease.

    AFFILIATION: Institute of Clinical Pharmacology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China. weimincai@263.net.

    Country: China

    China Research PublicationChina Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Acta Pharmacol Sin

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Effect of MDR1 gene polymorphism on progression of end-stage renal disease Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News